BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fultang N, Illendula A, Lin J, Pandey MK, Klase Z, Peethambaran B. ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1. Sci Rep 2020;10:1821. [PMID: 32020017 DOI: 10.1038/s41598-020-58864-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Vicentini SNC, Moreira SI, da Silva AG, de Oliveira TYK, Silva TC, Assis Junior FG, Krug LD, de Paiva Custódio AA, Leite Júnior RP, Teodoro PE, Fraaije B, Ceresini PC. Efflux Pumps and Multidrug-Resistance in Pyricularia oryzae Triticum Lineage. Agronomy 2022;12:2068. [DOI: 10.3390/agronomy12092068] [Reference Citation Analysis]
2 Tilsed CM, Fisher SA, Nowak AK, Lake RA, Lesterhuis WJ. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front Oncol 2022;12:960317. [DOI: 10.3389/fonc.2022.960317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tarakanova VO, Krakhmal NV, Patalyak SV, Tarasov MN, Babyshkina NN, Vtorushin SV. ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer. Sib onkol ž 2022;21:135-142. [DOI: 10.21294/1814-4861-2022-21-3-135-142] [Reference Citation Analysis]
4 Modi A, Roy D, Sharma S, Vishnoi JR, Pareek P, Elhence P, Sharma P, Purohit P. ABC transporters in breast cancer: their roles in multidrug resistance and beyond. J Drug Target 2022;:1-21. [PMID: 35758271 DOI: 10.1080/1061186X.2022.2091578] [Reference Citation Analysis]
5 Zarrineh M, Ashrafian S, Jensen P, Nawrocki A, Ansari AM, Rezadoost H, Ghassempour A, Larsen MR. Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines. J Proteomics 2022;259:104539. [PMID: 35240313 DOI: 10.1016/j.jprot.2022.104539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kara G. siRNA targeting ABCB1 potentiates the efficacy of chemotherapy in human triple-negative breast cancer cells. HJBC 2022. [DOI: 10.15671/hjbc.975466] [Reference Citation Analysis]
7 Rustagi V, Nagar G, Mittal P, Singh A, Singh IK. Receptor tyrosine kinase-like orphan receptors ROR1/2: Insights into the mechanism of action, inhibition, and therapeutic potential. Protein Kinase Inhibitors 2022. [DOI: 10.1016/b978-0-323-91287-7.00018-1] [Reference Citation Analysis]
8 Pereira MA, de Oliveira Marinho FL, Leite LR, Alvim LB, Malta FSV, Marques FK, de Lima AB. Breast Cancer and Next-Generation Sequencing: Towards Clinical Relevance and Future. Breast Cancer: From Bench to Personalized Medicine 2022. [DOI: 10.1007/978-981-19-0197-3_20] [Reference Citation Analysis]
9 Korszun J. The development of multidrug resistance in cancer cells: the potential of ABC transporter-targeted therapy to overcome inefficiency of treatment. FBOe 2021;17:7-8. [DOI: 10.18778/1730-2366.16.04] [Reference Citation Analysis]
10 Qin AC, Qian Y, Ma YY, Jiang Y, Qian WF. Long Non-coding RNA RP11-395G23.3 Acts as a Competing Endogenous RNA of miR-124-3p to Regulate ROR1 in Anaplastic Thyroid Carcinoma. Front Genet 2021;12:673242. [PMID: 34421987 DOI: 10.3389/fgene.2021.673242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Z, Chen C, Chen L, Hu D, Yang X, Zhuo W, Chen Y, Yang J, Zhou Y, Mao M, Zhang X, Xu L, Ju S, Shen J, Wang Q, Dong M, Xie S, Wei Q, Jia Y, Zhou J, Wang L. STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1. Front Oncol 2021;11:697950. [PMID: 34336684 DOI: 10.3389/fonc.2021.697950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Shan Y, Huang Y, Lee AM, Mentzer J, Ling A, Huang RS. A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer. Front Oncol 2021;11:675215. [PMID: 34094978 DOI: 10.3389/fonc.2021.675215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sreekumar R, Al-Saihati H, Emaduddin M, Moutasim K, Mellone M, Patel A, Kilic S, Cetin M, Erdemir S, Navio MS, Lopez MA, Curtis N, Yagci T, Primrose JN, Price BD, Berx G, Thomas GJ, Tulchinsky E, Mirnezami A, Sayan AE. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. Mol Oncol 2021;15:2065-83. [PMID: 33931939 DOI: 10.1002/1878-0261.12965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Roarty K, Echeverria GV. Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. Front Oncol 2021;11:645698. [PMID: 33777805 DOI: 10.3389/fonc.2021.645698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Mehdizadehtapeh L, Obakan Yerlİkaya P. Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors. Turk J Biol 2021;45:1-16. [PMID: 33597817 DOI: 10.3906/biy-2010-62] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Menck K, Heinrichs S, Baden C, Bleckmann A. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention. Cells 2021;10:142. [PMID: 33445713 DOI: 10.3390/cells10010142] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
17 Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Rahmani Moghadam E, Raei M, Kalantari M, Tavakol S, Mohammadinejad R, Najafi M, Tay FR, Makvandi P. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Comb Sci 2020;22:669-700. [PMID: 33095554 DOI: 10.1021/acscombsci.0c00099] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 19.5] [Reference Citation Analysis]
18 Dobre EG, Dinescu S, Costache M. Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer. Cancers (Basel) 2020;12:E2698. [PMID: 32967267 DOI: 10.3390/cancers12092698] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
19 Illendula A, Fultang N, Peethambaran B. Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements. Oncol Rep 2020;44:1013-24. [PMID: 32705280 DOI: 10.3892/or.2020.7681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]